Hyloris Pharmaceuticals SA (LON: 0AB6)
London
· Delayed Price · Currency is GBP · Price in EUR
5.58
-0.26 (-4.45%)
At close: Jan 23, 2025
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of 125.97 million as of January 31, 2025. Its market cap has decreased by -57.74% in one year.
Market Cap
125.97M
Enterprise Value
104.17M
Revenue
5.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.58
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 224.34M to 125.97M, a decrease of -43.85%. That is a compound annual growth rate of -11.80%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jan 31, 2025 | 125.97M | -16.82% |
Dec 31, 2024 | 151.44M | -51.12% |
Dec 29, 2023 | 309.80M | 12.35% |
Dec 30, 2022 | 275.75M | -26.54% |
Dec 31, 2021 | 375.35M | 70.71% |
Dec 31, 2020 | 219.88M | -1.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 175.89B |
Shell | 163.79B |
HSBC Holdings | 148.66B |
Unilever | 120.06B |
Rio Tinto Group | 83.08B |
RELX PLC | 74.57B |
British American Tobacco p.l.c. | 70.36B |
BP p.l.c. | 66.36B |